Paragangliomas

Sternberg's Diagnostic Surgical Pathology: Fifth Edition

Volumn 1-2, Issue , 2010, Pages 587-610

  Lack, Ernest E ^a   Wieneke, Jacqueline A ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988837615     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (286)

1. Smetana HF, Scott WF Jr. Malignant tumors of nonchromaffin paraganglia. Mil Surgeon 1951;69:330-349.
2. Pearse AGE. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem1969;17:303-313.
3. Pearse AGE. The APUD cell concept and its implications in pathology. Pathol Annu 1974; 9:27-41.
4. Andrew A. The APUD concept: where has it led us? Br Med Bull 1982;38:221-225.
5. Toni R. The neuroendocrine system: organization and homeostatic role. J Endocrinol Invest 2004;27(Suppl 6):35-47.
6. Tischler AS, Dichter MA, Biales B, et al. Neural properties of cultured human endocrine tumor cells of proposed neural crest origin. Science 1976;192:902-904.
7. Cryer PE. Physiology and pathophysiology of the sympathoadrenal neuroendocrine system. N Engl J Med 1980;303:436-444.
8. Wolfe HJ. Endocrine pathology: past, present, and future. In Kovacs K, Asa SL, eds. Functional Endocrine Pathology. New York, NY: Blackwell Scientific, 1991:3-14.
9. Pearse AGE, Polak JM, Rost FWD, et al. Demonstration of the neural crest origin of type I (APUD) cells in the avian carotid body, using a cytochemical marker system. Histochemie 1973;34:191-203.
10. Heymans C, Bouckhaert JJ, Dautrebande L. Sinus carotidien et reflexes respiratoires. II. Influences respiratoires reflexes de l'acidose, de l'alkalose, de l'anhydride carbonique, de l'ion hydrogene et de l'anoxéme: sinus carotidiens et échanges respiratoires dans les poumons et au dela des poumons. Arch Int Pharmacodyn Ther 1930;39:400-450.
11. Comroe JH Jr. The location and function of the chemoreceptors of the aorta. Am J Physiol 1939;127:176-191.
12. de Castro F. Sur la structure et l'innervation du sinus carotidien de l'homme et des mammifères: nouveau faits sur l'innervation et la fonction du glomus caroticum. Etudes anatomiques et physiologiques. Trab Lab Invest Biol Univ Madr 1928;25:331-380.
13. Montoro RJ, Urena J, Fernández-Chacón R, et al. Oxygen sensing by ion channels and chemotransduction in single glomus cells. J Gen Physiol 1996;107:133-143.
14. Acker H. The oxygen sensing signal cascade under the influence of reactive oxygen species. Philos Trans R Soc Lond B Biol Sci 2005;360:2201-2210.
15. Kemp PJ. Detecting acute changes in oxygen: will the real sensor please stand up? Exp Physiol 2006;92:829-834.
16. Prabhakar NR. O2 sensing at the mammalian carotid body: why multiple O2 sensors and the multiple transmitters? Exp Physiol 2006;1:17-23.
17. Baysal BE. A phenotypical perspective on Mammalian oxygen sensor candidates. Ann NY Acad Sci 2006;1073:221-233.
18. Ortega-Saenz P, Pascual A, Pirut JI, et al. Mechanisms of acute oxygen sensing by the carotid body: lessons from genetically modified animals. Respir Physiol Neurobiol 2007;157: 140-147.
19. Smith P, Jago R, Heath D. Anatomical variation and quantitative histology of the normal and enlarged carotid body. J Pathol 1982;137:287-304.
20. Lack EE, Perez-Atayde AR, Young JB. Carotid body hyperplasia in cystic fibrosis and cyanotic heart disease: a combined morphometric, ultrastructural and biochemical study. Am J Pathol 1985;119:301-314.
21. McCluggage WG, Young RH. Paraganglioma of the ovary: report of three cases of a rare ovarian neoplasm, including two exhibiting inhibin positivity. Am J Surg Pathol 2006;30: 600-605.
22. Arias-Stella J. Human carotid body at high altitude. Am J Pathol 1969;55:82a.
23. Arias-Stella J, Valcarcel J. Chief cell hyperplasia in the human carotid body at high altitudes: physiologic and pathologic significance. Hum Pathol 1976;7:361-373.
24. Saldana MJ, Salem LE, Travezan R. High altitude hypoxia and chemodectomas. Hum Pathol 1973;4:251-263.
25. Pacheco-Ojeda L, Durango E, Rodriquez C, et al. Carotid body tumors at high altitudes: Quito, Ecuador, 1987. World J Surg 1988;12:856-860.
26. Rodriguez-Cuevas S, Lopez-Garza J, Labastida-Almendaro S. Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level. Head Neck 1998;20:374-378.
27. Heath D, Edwards C, Harris P. Post-mortem size and structure of the human carotid body: its relation to pulmonary disease and cardiac hypertrophy. Thorax 1970;25:129-140.
28. Lack EE. Carotid body hypertrophy in patients with cystic fibrosis and cyanotic congenital heart disease. Hum Pathol 1977;8:39-51.
29. Wang ZY, Bisgard GE. Chronic hypoxia-induced morphological and neurochemical changes in the carotid body. Microsc Res Tech 2002;59:168-177.
30. Prabhakar NR, Jacono FJ. Cellular and molecular mechanisms associated with carotid body adaptations to chronic hypoxia. High Alt Med Biol 2005;6:112-120.
31. Lack EE. Hyperplasia of vagal and carotid body paraganglia in patients with chronic hypoxemia. Am J Pathol 1978;91:497-516.
32. Lack EE. Tumors of the adrenal glands and extra-adrenal paraganglia. In Atlas of Tumor Pathology. 4th series, fascicle 8. Washington, DC: Armed Forces Institute of Pathology, 2007.
33. Chedid A, Jao W. Hereditary tumors of the carotid bodies and chronic obstructive pulmonary disease. Cancer 1974;33:1635-1641.
34. Nissenblatt MJ. Cyanotic heart disease: low altitude risk for carotid body tumor? J Hosp Med J 1978;142:12-21.
35. Bockelman HW, Arya S, Gilbert EF. Cyanotic congenital heart disease with malignant paraganglioma. Cancer 1982;50:2513-2517.
36. Mulligan RM. Chemodectoma in the dog. Am J Pathol 1950;26:680-681.
37. Marchand F. Beitrage zur Kenntniss der normalen und pathologischen anatomie der grandula carotica und der nebennieren. Int Beitr Z Wissensch Med Festschr R Virchow 1891; 1:535-581.
38. Lack EE. Pathology of Adrenal and Extra-Adrenal Paraganglia. Major Problems in Pathology. Vol.29. Philadelphia, PA: WB Saunders, 1994.
39. Oberman HA, Holtz F, Sheffer LA, et al. Chemodectomas (nonchromaffin paragangliomas) of the head and neck. Cancer 1968;21:838-851.
40. Shamblin WR, ReMine WH, Sheps SG, et al. Carotid body tumor (chemodectoma): clinicopathologic analysis of ninety cases. Am J Surg 1971;122:732-739.
41. Lack EE, Cubilla AL, Woodruff JM, et al. Paragangliomas of the head and neck region. Cancer 1977;39:397-409.
42. Pellitteri PK, Rinaldo A, Myssiorek D, et al. Paragangliomas of the head and neck. Oral Oncol 2004;40:563-575.
43. Manolidis S, Shohet JA, Jackson CG, et al. Malignant glomus tumors. Laryngoscope 1999; 109:30-34.
44. Van der May AGL, Jansen FC, Van Baalen JM. Management of carotid body tumors. Otolaryngol Clin North Am 2001;34:907-923.
45. Patetsios P, Gable DR, Garrett WV, et al. Management of carotid body paragangliomas and review of a 30-year experience. Ann Vasc Surg 2002;16:331-338.
46. Kasper GC, Welling RE, Wladis AR, et al. A multidisciplinary approach to carotid paragangliomas. Vasc Endovascular Surg 2006;40:467-474.
47. Grufferman S, Gillman MW, Pasternak LR, et al. Familial carotid body tumors: case report and epidemiologic review. Cancer 1980;46:2112-2116.
48. Parry DM, Li FP, Strong LC, et al. Carotid body tumors in humans: genetics and epidemiology. J Natl Cancer Inst 1982;68:573-578.
49. Lattes R. Nonchromaffin paraganglioma of ganglion nodosum, carotid body, and aortic arch bodies. Cancer 1950;3:667-694.
50. Lattes R, McDonald JJ, Sproul E. Nonchromaffin paraganglioma of carotid body and orbit: report of a case. Ann Surg 1954;139:382-384.
51. Kafie FE, Freischlag JA. Carotid body tumors: the role of preoperative embolization. Ann Vasc Surg 2001;15:237-242.
52. Rakovich G, Ferraro P, Therasse E, et al. Preoperative embolization in the management of a mediastinal paraganglioma. Ann Thorac Surg 2001;72:601-603.
53. Guild SR. A hitherto unrecognized structure, the glomus jugularis, in man. Anat Rec 1941; 79:28A.
54. Guild SR. The glomus jugulare, a nonchromaffin paraganglion, in man. Ann Otol Rhinol Laryngol 1953;62:1045-1071.
55. Rosenwasser H. Carotid body tumor of the middle ear and mastoid. Arch Otolaryngol 1945; 41:64-67.
56. Jackson CG. Glomus tympanicum and glomus jugulare tumors. Otolaryngol Clin North Am 2001;34:941-969.
57. Netterville JL, Jackson CG, Miller FR, et al. Vagal paraganglioma: a review of 46 patients treated during 20-year period. Arch Otolaryngol Head Neck Surg 1998;124:1133-1140.
58. Sniezek JC, Netterville JL, Sabri AN, et al. Vagal paragangliomas. Otolaryngol Clin North Am 2001;34:925-939.
59. Lawson W, Zak FG. The glomus bodies ("paraganglia") of the human larynx. Laryngoscope 1974;803:98-110.
60. Myssiorek D, Halaas Y, Silver C, et al. Laryngeal and sinonasal paragangliomas. Otolaryngol Clin North Am 2001;34:971-981.
61. Gallivan MVE, Chun B, Rowden G, et al. Laryngeal paraganglioma: case report with ultrastructural analysis and literature review. Am J Surg Pathol 1979;3:85-92.
62. Woodruff JM, Shah JP, Huvos AG, et al. Neuroendocrine carcinomas of the larynx: a study of two types, one of which mimics thyroid medullary carcinoma. Am J Surg Pathol 1985;9: 771-790.
63. Woodruff JM, Senie RT. Atypical carcinoid tumor of the larynx: a critical review of the literature. ORL J Otorhinolaryngol Relat Spec 1991;53:194-209.
64. Ferlito A, Devaney KO, Rinaldo A. Neuroendocrine neoplasms of the larynx: advances in identification, understanding and management. Oral Oncol 2006;42:770-788.
65. Barnes L. Paraganglioma of the larynx: a critical review of the literature. ORL 1991;53: 220-234.
66. Myssiorek D, Rinaldo A, Barnes L, et al. Laryngeal paraganglioma: an updated critical review. Acta Otolaryngol 2004;124:995-999.
67. Becker AE. The glomera in the region of the heart and great vessels: a microscopicanatomical and histochemical study [M.D. Thesis]. Amsterdam, The Netherlands: Laboratory of Pathological Anatomy of the University of Amsterdam, 1966.
68. Lack EE, Stillinger RA, Colvin DB, et al. Aortico-pulmonary paraganglioma: report of a case with ultrastructural study and review of the literature. Cancer 1979;43:269-278.
69. Johnson TL, Lloyd RV, Shapiro B, et al. Cardiac paragangliomas: a clinicopathologic and immunohistochemical study of four cases. Am J Surg Pathol 1985;9:827-834.
70. Mikolaenko I, Galliani CA, Davis GG. Pigmented cardiac paraganglioma. Arch Pathol Lab Med 2001;125:680-682.
71. Fisher ER, Hazard JB. Nonchromaffin paraganglioma of the orbit. Cancer 1952;5:521-524.
72. Thacker WC, Duckworth JK. Chemodectoma of the orbit. Cancer 1969;23:1233-1238.
73. Thorbeck RV, Valentin OIM, Morales MR. Non-chromaffin paraganglioma of the orbit. Zentralbl Chir 1986;111:46-49.
74. Veda N, Yoshida A, Fukunishi R, et al. Nonchromaffin paraganglioma in the nose and paranasal sinuses. Acta Pathol Jpn 1985;35:489-495.
75. Watson DJ. Nasal paraganglioma. J Laryngol Otol 1988;102:526-529.
76. Mevio E, Bignami M, Luinetti O, et al. Acta Otorhinolaryngol Belg 2001;55:247-249.
77. Schuller DE, Lucas JG. Nasal paraganglioma: a case report. Arch Otolaryngol 1982;108: 667-670.
78. DeLozier HL. Chemodectoma of the cheek: a case report. Ann Otol Rhinol Laryngol 1983; 92:109-112.
79. Smith WT, Hughes B, Ermocilla R. Chemodectoma of the pineal region, with observations on the pineal body and chemoreceptor tissue. J Pathol Bacteriol 1966;92:69-76.
80. Bilbao JM, Horvath E, Kovacs K, et al. Intrasellar paraganglioma associated with hypopituitarism. Arch Pathol Lab Med 1978;102:95-98.
81. Sambaziotis D, Kontogeorgos G, Kovacs K, et al. Intrasellar paraganglioma presenting as nonfunctioning pituitary adenoma. Arch Pathol Lab Med 1999;123:429-432.
82. Buss DH, Marshall RB, Baird FG, et al. Paraganglioma of the thyroid gland. Am J Surg Pathol 1980;4:589-593.
83. Heppleston AG. A carotid body-like tumour in the lung. J Pathol Bacteriol 1958;75: 461-464.
84. Goodman ML, LaForet EG. Solitary primary chemodectomas of the lung. Chest 1972;61: 48-50.
85. Singh G, Lee RE, Brooks DH. Primary pulmonary paraganglioma: report of a case and review of the literature. Cancer 1977;40:2286-2289.
86. daSilva RA, Gross JL, Haddad FJ, et al. Primary pulmonary paraganglioma: case report and literature review. Clinics 2006;61:83-86.
87. Blessing MH, Hora BI. Glomera in der lunge des menschen. Z Zellforsch Mikrosk Anat 1968; 87:562-570.
88. Medaline NS, Mendelsohn MG, Esposito M. Multicentric metachronous pulmonary and intravagal paraganglioma: a case report with immunohistochemical findings. Arch Pathol Lab Med 1996;120:1137-1140.
89. Dahir KM, Gonzalez A, Revelo MP, et al. Ectopic adrenocorticotropic hormone hypersecretion due to a primary pulmonary paraganglioma. Endocr Pract 2004;10:424-428.
90. Saeki T, Akiba T, Jon K, et al. An extremely large solitary paraganglioma of the lung: report of a case. Surg Today 1999;29:1195-1200.
91. Lack EE, Cubilla AL, Woodruff JM. Paragangliomas of the head and neck region: a pathologic study of tumors from 71 patients. Hum Pathol 1979;10:191-218.
92. Nora JD, Hallett JW Jr, O'Brien PC, et al. Surgical resection of carotid body tumors: longterm survival, recurrence, and metastasis. Mayo Clin Proc 1988;63:348-352.
93. Davidge-Pitts KJ, Pantanowitz D. Carotid body tumors. Surg Annu 1984;16:203-227.
94. Sacher M, Som PM, Lanzieri CF, et al. Total internal carotid artery occlusion by a benign carotid body tumor: a rare occurrence. J Comput Tomogr 1985;9:213-217.
95. Warshawski ST, de Souza FM. The carotid body tumor. J Otolaryngol 1989;18:306-310.
96. Roland PS. Malignant paraganglioma with retrograde flow in the internal carotid artery. Ann Otol Rhinol Laryngol 1991;100:345-347.
97. Grimley PM, Glenner CG. Histology and ultrastructure of carotid body paragangliomas: comparison with the normal gland. Cancer 1967;20:1473-1488.
98. LeCompte PM. Tumors of the carotid body and related structures (chemoreceptor system). In Atlas of Tumor Pathology. 1st series, fascicle 16. Washington, DC: Armed Forces Institute of Pathology, 1951.
99. Capella C, Solcia E. Optical and electron microscopical study of cytoplasmic granules in human carotid body, carotid body tumours and glomus jugulare tumours. Virchows Arch B Cell Pathol 1971;7:37-53.
100. Coupland RE. The Natural History of the Chromaffin Cell. London, United Kingdom: Longmans, Green, 1965.
101. Zuckerkandl E. Ueber nebenorgane des sympathicus im retroperitonaealraum des menschen. Verh Dtsch Anat Ges 1901;15:95-107.
102. Zuckerkandl E. The development of the chromaffin organs and of the suprarenal glands. In Keibel F, Mall EP, eds. Manual of Human Embryology. Philadelphia, PA: JB Lippincott, 1912:157-159.
103. Lack EE, Kozakewich HPW. Embryology, developmental anatomy, and selected aspects of non-neoplastic pathology. In Lack EE, ed. Pathology of the Adrenal Glands. New York, NY: Churchill Livingstone, 1990:1-74.
104. Coupland RE. Post-natal fate of the abdominal para-aortic bodies in man. J Anat 1954;88:455-464.
105. West GB, Shepherd DM, Hunter RB. The function of the organs of Zuckerkandl. Clin Sci 1953;12:317-325.
106. Lack EE. Adrenal medullary hyperplasia and pheochromocytoma. In Lack EE, ed. Pathology of the Adrenal Glands. New York, NY: Churchill Livingstone, 1990:173-235.
107. Ross JH. Pheochromocytoma. Special considerations in children. Ped Urol Oncol 2000;27:393-402.
108. Tekautz TM, Pratt CB, Jenkins JJ, et al. Pediatric extra adrenal paraganglioma. J Pediatr Surg 2003;38:1317-1321.
109. Fries JG, Chamberlin JA. Extra-adrenal pheochromocytoma: literature review and report of a cervical pheochromocytoma. Surgery 1968;63:268-279.
110. Miller TA, Weber TR, Appelman HD. Paraganglioma of the gallbladder. Arch Surg 1972;105:637-639.
111. Cho Yu, Kim JY, Choi SK, et al. A case of hemorrhagic gallbladder paraganglioma causing acute cholecystitis. Yonsei Med J 2001;42:352-356.
112. Eusebi V, Massarelli G. Pheochromocytoma of the spermatic cord: report of a case. J Pathol 1971;105:283-284.
113. Bacchi CE, Schmidt RA, Brandao M, et al. Paraganglioma of the spermatic cord: report of a case with immunohistochemical and ultrastructural studies. Arch Pathol Lab Med 1990;114:899-901.
114. Nielsen VM, Skovgaard N, Kvist N. Phaeochromocytoma of the prostate. Br J Urol 1987;59:478-479.
115. Campodonico F, Bandelloni R, Maffezzini M. Paraganglioma of the prostate in a young adult. Urology 2005;66:657.
116. Altavilla G, Cavazzini L, Russo R. Secreting benign paraganglioma of the prostatic urethra. Tumori 1983;69:79-82.
117. Parithivel VS, Niazi M, Malhotra AK, et al. Paraganglioma of the pancreas. Literature review and case report. Dig Dis Sci 2000;45:438-441.
118. Young TW, Thrasher TV. Nonchromaffin paraganglioma of the uterus. Arch Pathol Lab Med 1982;106:608-609.
119. Tavassoli FA. Melanotic paraganglioma of the uterus. Cancer 1986;58:942-948.
120. Glenner GG, Crout JR, Roberts WC. A functional carotid-body-like tumor secreting levarterenol. Arch Pathol 1962;73:230-240.
121. Crowell WT, Grizzle WE, Siegel AL. Functional carotid paragangliomas: biochemical, ultrastructural, and histochemical correlation with clinical symptoms. Arch Pathol Lab Med 1982;106:599-603. 1
122. Karasov RS, Sheps SG, Carney JA, et al. Paragangliomatosis with numerous catecholamine producing tumors. Mayo Clin Proc 1982;57:590-595.
123. Lack EE, Cubilla AL, Woodruff JM, et al. Extra adrenal paragangliomas of the retroperitoneum: a clinicopathologic study of 12 tumors. Am J Surg Pathol 1980;4:109-120.
124. Leestma JE, Price EB Jr. Paragangliomas of the urinary bladder. Cancer 1971;28:1063-1072.
125. Gallivan MVE, Chun B, Rowden G, et al. Intrathoracic paravertebral malignant paraganglioma. Arch Pathol Lab Med 1980;104:46-51.
126. DeLellis RA, Suchow E, Wolfe HJ. Ultrastructure of nuclear inclusions in pheochromocytoma and paraganglioma. Hum Pathol 1980;11:205-207.
127. Brody S, Leehan RM, Schwaitzberg SD, et al. Composite pheochromocytoma/ganglioneuroma of the adrenal gland associated with multiple endocrine neoplasia 2A: case report with immunohistochemical analysis. Am J Surg Pathol 1997;21:102-108.
128. Sakaguchi N, Sano K, Ito M, et al. A case of von Recklinghausen's disease with bilateral pheochromocytoma: malignant peripheral nerve sheath tumor of the adrenal and gastrointestinal autonomic nerve tumors. Am J Surg Pathol 1996;20:889-897.
129. Wieneke JA, Thompson LDR, Heffess CS. Corticomedullary mixed tumor of the adrenal gland. Ann Diagn Pathol 2001;5:304-308.
130. Cheng L, Leibovich BC, Cheville JC, et al. Paraganglioma of the urinary bladder. Can biologic potential be predicted? Cancer 2000;88:844-852.
131. Yoshida S, Nakagomi K, Goto S, et al. Malignant pheochromocytoma of the urinary bladder: effectiveness of radiotherapy in conjunction with chemotherapy. Int J Urol 2004;11: 175-177.
132. Kovacs K, Bell D, Gardiner GW, et al. Malignant paraganglioma of the urinary bladder: immunohistochemical study of prognostic indicators. Endocr Pathol 2005;16:363-369.
133. Havekes B, Corssmit EP, Hansen JC, et al. Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab 2007;92: 1245-1248.
134. Linnoila RI, Keiser HR, Steinberg SM, et al. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol1990;21:1168-1180.
135. Medeiros LJ, Wolf BC, Balogh K, et al. Adrenal pheochromocytoma: a clinicopathologic review of 60 cases. Hum Pathol 1985;16:580-589.
136. Mendelsohn G, Olson JL. Pheochromocytomas [Letter]. Hum Pathol 1978;9:607-608.
137. Lack EE, Travis WD, Oertel JE. Adrenal cortical neoplasms. In Lack EE, ed. Pathology of the Adrenal Glands. New York, NY: Churchill Livingstone, 1990:115-171.
138. Lack EE, Mulvihill JJ, Travis WD, et al. Adrenal cortical neoplasms in the pediatric and adolescent age group: clinicopathologic study of 30 cases with emphasis on epidemiological and prognostic factors. Pathol Annu1992;27:1-53.
139. Rey C, Escribano JC, Vidal MT. Retroperitoneal para ganglioma and systemic amyloidosis: a case report. Cancer 1979;43:702-706.
140. Steinhoff MM, Wells SA Jr, DeSchryver-Kecskemeti K. Stromal amyloid in pheochromocytomas. Hum Pathol 1992;23:33-36.
141. Miranda RN, Wu CD, Nayak RN, et al. Amyloid in adrenal gland pheochromocytomas. Arch Pathol Lab Med 1995;119:827-830.
142. Bellezza G, Giansanti M, Cavaliere A, et al. Pigmented "black" pheochromocytoma of the adrenal gland: a case report and review of the literature. Arch Pathol Lab Med 2004; 128:125-128.
143. Lack EE, Kim H, Reed K. Pigmented (black) extra-adrenal paraganglioma. Am J Surg Pathol 1998;22:265-269.
144. Neumann HP, Cybulla M, Shibata H, et al. New genetic causes of pheochromocytoma: current concepts and the clinical relevance. Keio J Med 2005;54:15-21.
145. Elder EE, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 2005;89:193-201.
146. Chase WH. Familial and bilateral tumors of the carotid body. J Pathol Bacteriol 1933;36: 1-12.
147. Kroll AJ, Alexander B, Cochios F, et al. Hereditary deficiencies of clotting factors VII and X associated with carotid body tumors. N Engl J Med 1964;270:6-13.
148. Van Baars F, Cremers C, Van den Broek P, et al. Familial nonchromaffin paragangliomas (glomus tumors). Acta Otolaryngol 1981;91:589-593.
149. Sobol SM, Dailey JC. Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg 1990;102:382-390.
150. Pratt LW. Familial carotid body tumors. Arch Otolaryngol 1973;97:334-336.
151. Van der May AGL, Maaswinkel-Mooy PD, Cornelisse CJ, et al. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 1989;2:1291-1294.
152. Baysal BE. Genomic imprinting and environment in hereditary paraganglioma. Am J Med Genet C Semin Med Genet 2004;129:85-90.
153. Parkin JL. Familial multiple glomus tumors and pheochromocytomas. Ann Otol 1981;90: 60-63.
154. van Baars F, van den Broek P, Cremers C, et al. Familial non-chromaffin paragangliomas (glomus tumors): clinical aspects. Laryngoscope 1981;91:988-996.
155. Baysal BE. Genetics of familial paragangliomas. Otolaryngologic Clin North Am 2001;34:863-879.
156. Blank RD, Sklar CA, Dimich AB, et al. Clinical presentations and RET protooncogene mutations in seven multiple endocrine neoplasia type 2 kindreds. Cancer 1996;78: 1996-2003.
157. Eng C. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N Engl J Med 1996;335:943-951.
158. Astuti D, Douglas F, Leonard TWJ, et al. Germline SDHD mutation in familial pheochromocytomas. Lancet 2001;357:1181-1182.
159. Lui WO, Chen J, Glasker S, et al. Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome. Oncogene 2002;21:1117-1122.
160. Edstrom E, Mahlamaki E, Nord B, et al. Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. Am J Pathol 2000;156:651-659.
161. Webb TA, Sheps SG, Carney JA. Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrine neoplasia type 2. Am J Surg Pathol 1980;4: 121-126.
162. Carney JA, Sizemore GW, Tyce GM. Bilateral adrenal medullary hyperplasia in multiple endocrine neoplasia, type 2: the precursor of bilateral pheochromocytoma. Mayo Clin Proc 1975;50:3-10.
163. DeLellis RA, Wolfe HJ, Gagel RF, et al. Adrenal medullar hyperplasia: a morphometric analysis in patients with familial medullary thyroid carcinoma. Am J Pathol 1976;83: 177-190.
164. Carney JA, Sizemore GW, Sheps SG. Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursors. Am J Clin Pathol 1976;66: 279-290.
165. Keiser HR, Doppman JL, Robertson CN, et al. Diagnosis, localization, and management of pheochromocytoma. In Lack EE, ed. Pathology of the Adrenal Glands. New York, NY: Churchill Livingstone, 1990:237-255.
166. Carney JA, Sheps SG, Go VLW, et al. The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med 1977;296: 1517-1518.
167. Diment J, Tamborinin E, Casali P, et al. Carney triad: case report and molecular analysis of gastric tumor. Hum Pathol 2005;336:112-116.
168. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis and differential diagnosis. Arch Pathol Lab Med 2006;130:1466-1478.
169. Carney JA. Gastric stromal sarcoma, pulmonary chondroma and extra-adrenal paraganglioma (Carney triad): natural history, adrenocortical component and possible familial occurrence. Mayo Clin Proc 1999;74:543-552.
170. Matyakhina L, Bei TA, McWhinney SR, et al. Genetics of Carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab 2007;92:2938-2943.
171. Agaimy A, Pelz AF, Corless CL, et al. Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. Oncol Rep 2007;18:9-15.
172. Carney JA. The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma and functioning extra-adrenal paraganglioma: a five-year review. Medicine 1983;62:159-169.
173. Dunn GD, Brown MJ, Sapsford RN, et al. Functioning middle mediastinal paraganglioma (phaeochromocytoma) associated with intercarotid paragangliomas. Lancet 1986;1: 1061-1064.
174. Albores-Saavedra J, Devián ME. Association of thyroid carcinoma and chemodectoma. Am J Surg 1968;116:887-890.
175. Steely WM, Davies RS, Brigham RA. Carotid body tumor and hyperparathyroidism: a case report and review of the literature. Am Surg 1987;53:337-338.
176. Palmer FJ, Sawyers TM. Hyperparathyroidism, chemodectoma, thymoma, and myasthenia gravis. Arch Intern Med 1978;138:1402-1403.
177. Larraza-Hernandez O, Albores-Saavedra J, Benavides G, et al. Multiple endocrine neoplasia: pituitary adenoma, multicentric papillary thyroid carcinoma, bilateral carotid body paraganglioma, parathyroid hyperplasia, gastric leiomyoma and systemic amyloidosis. Am J Clin Pathol 1982;78:527-532.
178. Berg B, Biörklund A, Grimelius L, et al. A new pattern of multiple endocrine adenomatosis: chemodectoma, bronchial carcinoid, GH-producing pituitary adenoma, and hyperplasia of the parathyroid glands and antral and duodenal gastrin cells. Acta Med Scand 1976;200:321-326.
179. Carney JA, Stratakis CA. Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet 2002;108:132-139.
180. Engzell U, Franzen S, Zajicek J. Aspiration biopsy of tumors of the neck. II. Cytologic findings in 13 cases of carotid body tumor. Acta Cytol 1971;15:25-30.
181. Jacobs DM, Waisman J. Cervical paraganglioma with intranuclear vacuoles in a fine needle aspirate. Acta Cytol 1987;31:29-32.
182. González-Cámpora R, Otal-Salaverri C, Panea-Flores P, et al. Fine needle aspiration cytology of paraganglionic tumors. Acta Cytol 1988;32:386-390.
183. Qizilbash AH, Young JEM. Guides to Clinical Aspiration Biopsy: Head and Neck. New York, NY: Igaku-Shoin, 1988;279-289.
184. Fleming MV, Oertel YC, Rodriguez ER, et al. Fine-needle aspiration of six carotid body paragangliomas. Diagn Cytopathol 1993:9:510-515.
185. Zaharopoulos P. Diagnostic challenges in the fine-needle aspiration diagnosis of carotid body paragangliomas: report of five cases. Diagn Cytopathol 2000;23:202-207.
186. Nguyen G-K. Cytopathologic aspects of adrenal pheochromocytoma in a fine needle aspiration biopsy: a case report. Acta Cytol 1982;26:354-358.
187. McCorkell SJ, Niles NL. Fine needle aspiration of catecholamine-producing adrenal masses: a possibly fatal mistake. AJR Am J Roentgenol 1985;145:113-114.
188. Lambert MA, Hirschowitz L, Russell RCG. Fine needle aspiration biopsy: a cautionary tale. Br J Surg 1985;72:364.
189. Grimley PM. Tumors of the extra-adrenal paraganglia system (including chemoreceptors). In Atlas of Tumor Pathology 2nd series, fascicle 9. Washington, DC.: Armed Forces Institute of Pathology; 1974.
190. Tannenbaum M. Ultrastructural pathology of adrenal medullary tumors. Pathol Annu 1970;5:145-171.
191. Lloyd RV, Sisson JC, Shapiro B, et al. Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes, and chromogranin in neuroendocrine cells and tumors. Am J Pathol1986;125:45-54.
192. Capella C, Riva C, Cornaggia M, et al. Histopathology, cytology and cytochemistry of pheochromocytomas and paragangliomas including chemodectomas. Pathol Res Pract 1988;183:176-187.
193. Warren WH, Lee I, Gould VE, et al. Paragangliomas of head and neck: ultrastructural and immunohistochemical analysis. Ultrastr Pathol 1985;8:333-343.
194. Johnson TL, Zarbo RJ, Lloyd RV, et al. Paragangliomas of the head and neck: immunohistochemical, neuroendocrine and intermediate filament typing. Mod Pathol 1988;1: 216-223.
195. McNicol AM. Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas. Endocr Pathol 2006;17:329-336.
196. Kimura N, Sasano N, Yamada R, et al. Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumor, medullary thyroid carcinoma and carcinoid tumour. Virchows Arch A Pathol Anat Histopathol 1988;413:33-38.
197. Chetty R, Pillay P, Jaichand V. Cytokeratin expression in adrenal phaeochromcytomas and extra-adrenal paragangliomas. J Clin Pathol 1998;51:477-478.
198. Lehto V-P, Virtanen I, Miettinen M, et al. Neurofilaments in adrenal and extra-adrenal pheochromocytoma: demonstration using immunofluorescence microscopy. Arch Pathol Lab Med 1983;107:492-494.
199. Mukai M, Torikata C, Iri H, et al. Expression of neurofilament triplet proteins in human neural tumors: an immunohistochemical study of paraganglioma, ganglioneuroma, ganglioneuroblastoma, and neuroblastoma. Am J Pathol 1986;122:28-35.
200. Miettinen M. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors. Arch Pathol Lab Med 1987;3:813-818.
201. Linnoila RI, Lack EE, Steinberg SM, et al. Decreased expression of neuropeptides in malignant paragangliomas: an immunohistochemical study. Hum Pathol 1988;19:41-50.
202. Moyana TN, Kontozoglou T. Urinary bladder paragangliomas: an immunohistochemical study. Arch Pathol Lab Med 1988;112:70-72.
203. Grignon DT, Ro JY, Mackay B, et al. Paraganglioma of the urinary bladder: immunohistochemical, ultrastructural and DNA flow cytometric studies. Hum Pathol 1991;22: 1162-1169.
204. Spark RF, Connolly PB, Gluckin DS, et al. ACTH secretion from a functioning pheochromocytoma. N Engl J Med 1979;301:416-418.
205. Dahir KM, Gonzalez A, Revelo MP, et al. Ectopic adrenocorticotropic hormone hypersecretion due to a primary pulmonary paraganglioma. Endocr Pract 2004;10:424-428.
206. Otsuka F, Miyoshi T, Murakami K, et al. An extra-adrenal abdominal pheochromocytoma causing ectopic ACTH Syndrome. Am J Hypertens 2005;18:1364-1368.
207. Willenberg HS, Feldkamp J, Lehmann R, et al. A case of catecholamine and glucocorticoid excess syndrome due to a corticotropin-secreting paraganglioma. Ann NY Acad Sci 2006; 1073:52-58.
208. Trump DL, Livingston JN, Baylin SB. Watery diarrhea syndrome in an adult with ganglioneuroma-pheochromocytoma: identification of vasoactive intestinal peptide, calcitonin, and catecholamines and assessment of their biologic activity. Cancer 1977;40:1526-1532.
209. Viale G, Dell'Orto P, Moro E, et al. Vasoactive intestinal polypeptide-, somatostatin-, and calcitonin-producing adrenal pheochromocytoma associated with the watery diarrhea (WDHA) syndrome: first case report with immunohistochemical findings. Cancer 1985; 55:1099-1106.
210. Quarles Van Ufford-Mannesse P, Castro Cabezas M, Vroom TM, et al. A patient with neurofibromatosis type 1 and watery diarrhoea syndrome due to a VIP-producing adrenal phaeochromocytoma. J Intern Med1999;246:231-234.
211. Tischler AS, Dayal Y, Balogh K, et al. The distribution of immunoreactive chromogranins, S-100 protein, and vasoactive intestinal peptide in compound tumors of the adrenal medulla. Hum Pathol 1987;18:909-917.
212. Mendelsohn G, Eggleston JC, Olson JL, et al. Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors. Lab Invest 1979;41:144-149.
213. Koch CA, Vortmeyer AO, Diallo R, et al. Survivin: a novel neuroendocrine marker for pheochromocytoma. Eur J Endocrinol 2002;146:381-388.
214. de Krijger RR, van der Harst E, van der Ham F, et al. Prognostic value of p53, bcl-2 and c-erb-2 protein expression in pheochromocytomas. J Pathol 1999;188:51-55.
215. Gimm O, Krause U, Brauckhoff M, et al. Distinct expression of galectin-3 in pheochromocytomas. Ann NY Acad Sci. 2006;1073:571-577.
216. Miettinen M. Neuroendocrine differentiation in adrenocortical carcinoma: new immunohistochemical findings supported by electron microscopy. Lab Invest 1992;66:169-174.
217. Zhang PJ, Genega EM, Tomaszewski JE, et al. The role of calretinin, inhibin, melan-A, bcl-2 and c-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Mod Pathol 2003;16:591-597.
218. Hamid Q, Verndell IM, Ibrahim NB, et al. Extra-adrenal paragangliomas: an immunohistochemical and ultrastructural report. Cancer 1987;60:1776-1781.
219. Wang D-G, Barros D, Sa AAB, et al. Oncogene expression in carotid body tumors. Cancer 1996;77:2581-2587.
220. Granger JK, Houn H-Y. Head and neck paragangliomas: a clinicopathologic study with DNA flow cytometric analysis. South Med J 1990;83:1407-1412.
221. Barnes L, Taylor SR. Carotid body paragangliomas: a clinicopathologic and DNA analysis of 13 tumors. Arch Otolaryngol Head Neck Surg 1990;116:447-453.
222. Sauter ER, Hollier LH, Bolton JS, et al. Prognostic value of DNA flow cytometry in paragangliomas of the carotid body. J Surg Oncol 1991;46:151-153.
223. Van der Mey AGL, Cornelisse CJ, Hermans J, et al. DNA flow cytometry of hereditary and sporadic paragangliomas (glomus tumours). Br J Cancer 1991;63:298-302.
224. Hosaka Y, Rainwater LM, Grant CS, et al. Pheochromocytoma: nuclear deoxyribonucleic acid patterns studied by flow cytometry. Surgery 1986;100:1003-1010.
225. Amberson JB, Vaughan ED Jr, Gray GF, et al. Flow cytometric determination of nuclear DNA content in benign adrenal pheochromocytomas. Urology 1987;30:102-104.
226. Garcia-Escudero A, de Miguel-Rodriguez M, Moreno-Fernandez A, et al. Prognostic value of DNA flow cytometry in sympathoadrenal paragangliomas. Anal Quant Cytol Histol 2001; 23:238-244.
227. Douwes Dekker PB, Corver WE, Hogendoorn PC, et al. Multiparameter DNA flow-sorting demonstrates diploidy and SDHD wild-type gene retention in the sustentacular cell compartment of head and neck paragangliomas: chief cells are the only neoplastic component. J Pathol 2004;202:456-462.
228. Mauri MF, Mingazzini P, Sisti S, et al. Histomorphometric and morphologic studies of the carotid body and aortic paragangliomas. Appl Pathol 1989;7:310-317.
229. Brown HM, Komorowski RA, Wilson SD, et al. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation. A positive correlation between MIB-1 staining and malignant tumor behavior. Cancer 1999; 86:1583-1589.
230. Zbaren P, Lehmann W. Carotid body paraganglioma with metastases. Laryngoscope 1985; 95:450-454.
231. Heinrich MC, Harris AE, Bell WR. Metastatic intravagal paraganglioma: case report and review of the literature. Am J Med 1985;78:1017-1024.
232. Zak FG, Lawson W. The Paraganglionic Chemoreceptor System: Physiology, Pathology, and Clinical Medicine. New York, NY: Springer-Verlag, 1982.
233. Melicow MM. One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center 1926-1976: a clinicopathological analysis. Cancer 1977;40: 1987-2004.
234. Symington T, Goodall AL. Studies in pheochromocytoma. I. Pathological aspects. Glas Med J 1953:34:75-96.
235. Van Heerden JA, Sheps SG, Hamberger B, et al. Pheochromocytoma: current status and changing trends. Surgery 1982;91:367-373.
236. Olson JR, Abell MR. Nonfunctional nonchromaffin paragangliomas of the retroperitoneum. Cancer 1969;23:1358-1367.
237. Glenn F, Gray GF. Functional tumors of the organ of Zuckerkandl. Ann Surg 1976;183: 578-586.
238. Sclafani LM, Woodruff JM, Brennan MF. Extra adrenal retroperitoneal paragangliomas: natural history and response to treatment. Surgery 1990;108:1124-1130.
239. Odze R, Begin LR. Malignant paraganglioma of the posterior mediastinum: a case report and review of the literature. Cancer 1990;65:564-569.
240. Neville AM. The adrenal medulla. In Symington T, ed. Functional Pathology of the Human Adrenal Gland. Baltimore, MD: Williams & Wilkins, 1969:217-324.
241. Thompson LD. Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol2002;26:551-566.
242. Gao B, Meng F, Bian W, et al. Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas. Urology 2006; 68:282-286.
243. deKrijger RR, van Nederveen FH, Korpershoek E, et al. New developments in the detection of the clinical behavior of pheochromocytomas and paragangliomas. Endocr Pathol 2006;17:137-141.
244. Tischler AS, Kimura N, McNicol AM. Pathology of pheochromocytoma and extra-adrenal paraganglioma. Ann N Y Acad Sci 2006;1073:557-570.
245. Kimura N, Watanabe T, Noshiro T, et al. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 2005;16:23-32.
246. van der Harst E, Bruining HA, Jaap BH, et al. Proliferative index in pheochromocytomas: does it predict the occurrence of metastases? J Pathol 2000;191:175-180.
247. John H, Ziegler WH, Hauri D, et al. Pheochromocytomas: can malignant potential be predicted? Urology 1999;53:679-685.
248. Lloyd RV, Shapiro B, Sisson JC, et al. Paragangliomas: an immunohistochemical study of pheochromocytomas. Arch Pathol Lab Med 1984;108:541-544.
249. Lloyd RV, Blaivas M, Wilson BS. Distribution of chromogranin and S-100 protein in normal and abnormal adrenal medullary tissues. Arch Pathol Lab Med 1985;109:633-635.
250. Schroder HD, Johannsen L. Demonstration of S-100 protein in sustentacular cells of pheochromocytomas and paragangliomas. Histopathology 1986;10:1023-1033.
251. Kliewer KE, Wen D-R, Cancilla PA, et al. Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques. Hum Pathol 1989;20: 29-39.
252. Kliewer KE, Cochran AJ. A review of the histology, ultrastructure, immunohistology, and molecular biology of extra-adrenal paragangliomas. Arch Pathol Lab Med 1989;113: 1209-1218.
253. Bhansali SA, Bojrab DI, Zarbo RJ. Malignant paragangliomas of the head and neck: clinical and immunohistochemical characterization. Otolaryngol Head Neck Surg 1991;104:132.
254. Unger P, Hoffman K, Pertsemlidis D, et al. S-100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas. Arch Pathol Lab Med 1991; 115:484-487.
255. Helman LJ, Cohen PS, Averbuch SD, et al. Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma. J Clin Oncol 1989;7:1720-1725.
256. Furihata M, Ohtsuki Y. Immunohistochemical characterization of HLA-DR-antigen positive dendritic cells in pheochromocytomas and paragangliomas as a prognostic marker. Virchows Arch A Pathol Anat Histopathol1991;418:33-39.
257. Salmenkivi K, Haglund C, Arola J, et al. Increased expression of tenascin in pheochromocytomas correlates with malignancy. Am J Surg Pathol 2001;25:1419-1423.
258. Salmenkivi K, Haglund C, Ristimaki A, et al. Increased expression of cyclooxygenase-2 in malignant pheochromocytomas. J Clin Endocrinal Metab 2001;86:5615-5619.
259. Fuentes C, Menendez E, Pineda J, et al. The malignant potential of a succinate dehydrogenase subunit B germline mutation. J Endocrinol Invest 2006; 29:350-352.
260. Van Nederveen FH, Dinjens WN, Korpershoek E, et al. The occurrence of SDHB gene mutations in pheochromocytoma. Ann N Y Acad Sci 2006;1073:177-182.
261. Havekes B, Corssmit EP, Jansen JC, et al. Malignant paragangliomas associated with mutation in the succinate dehydrogenase D gene. J Clin Endocrinol Metab 2007;92:1245-1248.
262. Janetschek G, Neumann HP. Laparoscopic surgery for pheochromocytoma. Urol Clin North Am 2001;28:97-105.
263. Li ML, Fitzgerald PA, Price DC, et al. Iatrogenic pheochromocytomatosis: a previously unreported result of laparoscopic adrenalectomy. Surgery 2001;130:1072-1077.
264. Taylor HB, Helwig EB. Benign nonchromaffin paragangliomas of the duodenum. Virchows Arch A Pathol Anat Histopathol 1962;335:356-366.
265. Kepes JJ, Zacharias DL. Gangliocytic paragangliomas of the duodenum: a report of two cases with light and electron microscopic examination. Cancer 1971; 27:61-70.
266. Reed RJ, Daroca PL Jr, Harkin JC. Gangliocytic paraganglioma. Am J Surg Pathol 1977;1:207-216.
267. Perrone T, Sibley RK, Rosai J. Duodenal gangliocytic paraganglioma: an immunohistochemical and ultrastructural study and a hypothesis concerning its origin. Am J Surg Pathol 1985;9:31-41.
268. Hamid QA, Bishop AE, Rode J, et al. Duodenal gangliocytic paragangliomas: a study of 10 cases with immunocytochemical neuroendocrine markers. Hum Pathol 1986;17: 1151-1157.
269. Scheithauer BW, Nora FE, Lechago J, et al. Duodenal gangliocytic paraganglioma: clinicopathologic and immunocytochemical study of 11 cases. Am J Clin Pathol 1986;86:559-565.
270. Burke AP, Helwig EB. Gangliocytic paraganglioma. Am J Clin Pathol 1989;92:1-9.
271. van Eeden S, Offerhaus GJA, Peterse HL, et al. Gangliocytic paraganglioma of the appendix. Histopathology 2000;36:47-49.
272. Llena J, Wisoff HS, Hirano A. Gangliocytic paraganglioma in cauda equina region with biochemical and neuropathological studies. J Neurosurg 1982;56:280-282.
273. Witkiewicz A, Galler A, Yeo CJ, et al. Gangliocytic paraganglioma: case report and review of the literature. J Gastrointest Surg 2007;11:1351-1354.
274. Palau MA, Merino MJ, Quezado M. Corticotropin-producing pulmonary gangliocytic paraganglioma associated with Cushing's syndrome. Hum Pathol 2006;37:623-626.
275. Böker D-K, Wassman H, Solymosi L. Paragangliomas of the spinal canal. Surg Neurol 1983;19:461-468.
276. Lipper S, Decker RE. Paraganglioma of the cauda equina: a histologic, immunohistochemical, and ultrastructural study and review of the literature. Surg Neurol 1984;22:415-420.
277. Shuangshoti S, Suwanwela N, Suwanwela C. Combined paraganglioma and glioma of conus medullaris and cauda equina. J Surg Oncol 1984;25:162-167.
278. Sonneland PRL, Scheithauer BW, Lechago J, et al. Paraganglioma of the cauda equina region: clinicopathologic study of 31 cases with special reference to immunocytopathology and ultrastructure. Cancer1986;58:1720-1735.
279. Ashkenazi E, Onesti ST, Kader A, et al. Paraganglioma of the filum terminale: case report and literature review. J Spinal Disord 1998;11:540-542.
280. Labrousse F, Leboutet MJ, Petit B et al. Cytokeratin expression in paragangliomas of the cauda equine. Clin Neuropathol 1999;18:208-213.
281. Luschka H. Ueber die drüsenartige natur des sogenannten ganglion intercaroticum. Arch F Anat Physiol Wissensch Med Jahrq S 1862;405-414.
282. Hollinshead WH. A comparative study of the glomus coccygeum and the carotid body. Anat Rec 1942;84:1-13.
283. Albrecht S, Zbieranowski I. Incidental glomus coccygeum: when a normal structure looks like a tumor. Am J Surg Pathol 1990;14:922-924.
284. Gatalica Z, Wang L, Luci ET, et al. Glomus coccygeum in surgical pathology specimens: small troublemaker. Arch Pathol Lab Med 1990;123:905-908.
285. Santos LD, Chow C, Kennerson AR. Glomus coccygeum may mimic glomus tumour. Pathology 2002;34:339-343.
286. Rahemtullah A, Szyfelbein K, Zembowicz A. Glomus coccygeum: report of a case and review of the literature. Am J Dermatopathol 2005;27:497-499.